Artificial intelligence (AI) is revolutionising healthcare services

AI may improve clinical research through its ability to better translate RWD into RWE, thus providing more valid evidence of clinical benefits and risks. AI is poised to transform the drug and device development process, helping researchers refine the approval process and significantly cutting both the time and the expense needed to bring products to…

Read More

NHS has uniquely beneficial healthcare data and real-world evidence to improve oncology outcomes

Real-world evidence generated by the NHS has a broad range of applications in research that can inform regulatory filings by assessing safety and effectiveness, and then the cost-effectiveness, of new treatments. NICE, and other payers, are also actively encouraging and advocating the use of RWE to complement and reduce uncertainty in more traditional evidence in…

Read More

Real-world evidence in oncology: vitally relevant

Over time oncology practice has seen increased complexity of clinically relevant data recorded for patients, and improved methods of recording (including electronic medical records), which has resulted in increasing volumes of real-world data. Utilising this data has the potential to improve cancer care in many ways including: Help to inform clinical decisions in common settings…

Read More